BioCentury
ARTICLE | Clinical News

GelVac avian H5N1 influenza vaccine: Phase I start

January 21, 2008 8:00 AM UTC

This year, Carrington’s DelSite Biotechnologies Inc. unit will begin a dose-escalation, U.S. Phase I trial in healthy volunteers. ...